ART exerted its anticancer effects by inducing ROS production and DNA oxidative damage, thus activating the p53/Cdk4/6-p16-Rb cell cycle checkpoint control pathways in ESCC cells. This evidence concerns the gene CDK4 and esophageal squamous cell carcinoma.